Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Safety and Immunogenicity of A/California/7/2009 (H1N1)V-like Vaccines GSK2340273A and GSK2340274A in Adults Aged 18 Years and Older
Conditions
Interventions
GSK2340274A
GSK2340273A
+1 more
Locations
14
United States
GSK Investigational Site
Huntsville, Alabama, United States
GSK Investigational Site
Jacksonville, Florida, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Meridian, Idaho, United States
GSK Investigational Site
Lenexa, Kansas, United States
GSK Investigational Site
Missoula, Montana, United States
Start Date
October 11, 2009
Primary Completion Date
November 9, 2009
Completion Date
December 16, 2010
Last Updated
December 12, 2017
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions